{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:37:44Z","timestamp":1790761064406,"version":"4.1.0"},"reference-count":5,"publisher":"BMJ","issue":"10","funder":[{"name":"The Netherlands ALS Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2019,2,7]]},"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1136\/jnnp-2018-320211","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T22:19:22Z","timestamp":1551997162000},"page":"1183-1184","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Evidence for a multimodal effect of riluzole in patients with ALS?"],"prefix":"10.1136","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-3397","authenticated-orcid":false,"given":"Adriaan D","family":"de Jongh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7132-5967","authenticated-orcid":false,"given":"Ruben P A","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"2024111107500828000_90.10.1183.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91680-3"},{"key":"2024111107500828000_90.10.1183.2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1474-4422(18)30054-1","article-title":"Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study","volume":"17","author":"Fang","year":"2018","journal-title":"Lancet Neurol"},{"key":"2024111107500828000_90.10.1183.3","doi-asserted-by":"crossref","unstructured":"Hardiman O , Al-Chalabi A , Chio A , et al . Amyotrophic lateral sclerosis. Nat Rev Dis Primers 2017;3.doi:10.1038\/nrdp.2017.85","DOI":"10.1038\/nrdp.2017.71"},{"key":"2024111107500828000_90.10.1183.4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/21678421.2016.1188961","article-title":"Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS","volume":"17","author":"Geevasinga","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2024111107500828000_90.10.1183.5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/CLEP.S153196","article-title":"Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis","volume":"10","author":"van Eijk","year":"2018","journal-title":"Clin Epidemiol"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2018-320211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T15:50:21Z","timestamp":1731340221000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2018-320211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":5,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,12]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/jnnp-2018-320211"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2018-320211","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]}}}